These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31494989)

  • 21. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
    Niu N; Heberton MM; Tang Z; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC
    J Cutan Pathol; 2023 Aug; 50(8):711-716. PubMed ID: 36944579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.
    de la Garza Bravo MM; Patel KP; Loghavi S; Curry JL; Torres Cabala CA; Cason RC; Gangar P; Prieto VG; Medeiros LJ; Duvic M; Tetzlaff MT
    Hum Pathol; 2015 Apr; 46(4):558-69. PubMed ID: 25666664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD30+ lymphoproliferative disorder with spindle-cell morphology.
    Martires KJ; Cohen BE; Cassarino DS
    J Cutan Pathol; 2016 Nov; 43(11):1041-1044. PubMed ID: 27433975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study.
    AbuHilal M; Walsh S; Shear N
    J Cutan Med Surg; 2017; 21(6):507-512. PubMed ID: 28614957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Kempf W
    Surg Pathol Clin; 2014 Jun; 7(2):203-28. PubMed ID: 26837199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
    Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphomatoid Papulosis With a Unique T Follicular Helper-Like Phenotype.
    Tran J; Duvic M; Torres-Cabala CA
    Am J Dermatopathol; 2020 Oct; 42(10):776-779. PubMed ID: 32568843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphomatoid papulosis subtype C: A case report and literature review.
    Wang L; Chen F; Zhao S; Wang X; Fang J; Zhu X
    Dermatol Ther; 2021 Jan; 34(1):e14452. PubMed ID: 33099866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
    Schwartz Z; Bowe RB; Coleman M; Magro CM
    Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiopathogenesis, Diagnosis, and Treatment Strategies for Lymphomatoid Papulosis with Particular Emphasis on the Role of the Immune System.
    Nowicka D; Mertowska P; Mertowski S; Hymos A; Forma A; Michalski A; Morawska I; Hrynkiewicz R; Niedźwiedzka-Rystwej P; Grywalska E
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acral lymphomatoid papulosis: Report of five cases, differential diagnosis, and review.
    Machan S; Juárez Martín Á; Cullen Aravena D; Haro R; Pielasinski Ú; Fuertes L; Córdoba R; Santonja C; Rodríguez-Pinilla SM; Requena L
    J Cutan Pathol; 2021 May; 48(5):650-658. PubMed ID: 33269496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphomatoid papulosis: a model of lymphomagenesis.
    Kerrigan K
    Dermatol Nurs; 1994 Dec; 6(6):429-35. PubMed ID: 7727200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.
    Bhabha FK; McCormack C; Campbell BA; Lade S; Buelens O; Van Der Weyden C; Prince HM
    Australas J Dermatol; 2023 May; 64(2):194-203. PubMed ID: 36892928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
    Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
    Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphomatoid papulosis in a patient with Waldenström's macroglobulinemia.
    Ribeiro-Silva A; Chang D; Arruda D; Félix PR
    J Dermatol; 2005 Feb; 32(2):132-6. PubMed ID: 15906545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical Management of CD30⁺ Lymphoproliferative Disorders.
    Hughey LC
    Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Agminated CD30+ Lymphoproliferative Disorder.
    Beer J; Bittar PG; Bittar JM; Elenitsas R; Haun P
    J Drugs Dermatol; 2020 Oct; 19(10):1005-1007. PubMed ID: 33026773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphomatoid papulosis associated with recurrent cutaneous T-cell lymphoma.
    Tan AW; Giam YC
    Ann Acad Med Singap; 2004 Jan; 33(1):110-2. PubMed ID: 15008576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lymphomatoid papulosis type C or transition to CD30+-T-cell lymphoma? A difficult differential diagnosis].
    Plettenberg H; Neumann NJ; Ruzicka T; Megahed M
    Hautarzt; 2003 Apr; 54(4):366-8. PubMed ID: 12669213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.